Matches in SemOpenAlex for { <https://semopenalex.org/work/W4382752420> ?p ?o ?g. }
- W4382752420 endingPage "1183" @default.
- W4382752420 startingPage "1183" @default.
- W4382752420 abstract "Immune responses after COVID-19 vaccination should be evaluated in different populations around the world. This study compared antibody responses induced by ChAdOx1 nCoV-19, CoronaVac, and BNT162b2 vaccines. Blood samples from vaccinees were collected pre- and post-vaccinations with the second and third doses. The study enrolled 78 vaccinees, of whom 62.8% were women, with the following median ages: 26 years—ChAdOx1 nCoV-19; 40 years—CoronaVac; 30 years—BNT162b2. Serum samples were quantified for anti-RBD IgG and anti-RBD IgA and anti-spike IgG by ELISA. After two vaccine doses, BNT162b2 vaccinees produced higher levels of anti-RBD IgA and IgG, and anti-spike IgG compared to ChAdOx1 nCoV-19 and CoronaVac vaccinees. The third dose booster with BNT162b2 induced higher levels of anti-RBD IgA and IgG, and anti-spike IgG in CoronaVac vaccinees. Individuals who reported a SARS-CoV-2 infection before or during the study had higher anti-RBD IgA and IgG production. In conclusion, two doses of the studied vaccines induced detectable levels of anti-RBD IgA and IgG and anti-spike IgG in vaccinees. The heterologous booster with BNT162b2 increased anti-RBD IgA and IgG and anti-spike IgG levels in CoronaVac vaccinees and anti-RBD IgA levels in ChAdOx1 nCoV-19 vaccinees. Furthermore, SARS-CoV-2 infection induced higher anti-RBD IgA and IgG levels in CoronaVac vaccinees." @default.
- W4382752420 created "2023-07-01" @default.
- W4382752420 creator A5004509124 @default.
- W4382752420 creator A5022182326 @default.
- W4382752420 creator A5022556482 @default.
- W4382752420 creator A5036098046 @default.
- W4382752420 creator A5043985132 @default.
- W4382752420 creator A5044938943 @default.
- W4382752420 creator A5071213434 @default.
- W4382752420 creator A5078724506 @default.
- W4382752420 creator A5081286036 @default.
- W4382752420 creator A5087196296 @default.
- W4382752420 creator A5092371828 @default.
- W4382752420 date "2023-06-30" @default.
- W4382752420 modified "2023-09-27" @default.
- W4382752420 title "Heterologous Booster with BNT162b2 Induced High Specific Antibody Levels in CoronaVac Vaccinees" @default.
- W4382752420 cites W2013273227 @default.
- W4382752420 cites W2017699847 @default.
- W4382752420 cites W2028266585 @default.
- W4382752420 cites W2083958143 @default.
- W4382752420 cites W2739589307 @default.
- W4382752420 cites W2921553057 @default.
- W4382752420 cites W2999211024 @default.
- W4382752420 cites W3022917947 @default.
- W4382752420 cites W3023787531 @default.
- W4382752420 cites W3025631553 @default.
- W4382752420 cites W3039202106 @default.
- W4382752420 cites W3080999659 @default.
- W4382752420 cites W3082474729 @default.
- W4382752420 cites W3087648734 @default.
- W4382752420 cites W3087924281 @default.
- W4382752420 cites W3133646146 @default.
- W4382752420 cites W3142193311 @default.
- W4382752420 cites W3153468502 @default.
- W4382752420 cites W3158825740 @default.
- W4382752420 cites W3158928559 @default.
- W4382752420 cites W3162918018 @default.
- W4382752420 cites W3189544042 @default.
- W4382752420 cites W3192803358 @default.
- W4382752420 cites W3194598131 @default.
- W4382752420 cites W3196028820 @default.
- W4382752420 cites W3199424695 @default.
- W4382752420 cites W3204932209 @default.
- W4382752420 cites W3209618822 @default.
- W4382752420 cites W4200113420 @default.
- W4382752420 cites W4205284298 @default.
- W4382752420 cites W4206906464 @default.
- W4382752420 cites W4206922457 @default.
- W4382752420 cites W4210844692 @default.
- W4382752420 cites W4212880839 @default.
- W4382752420 cites W4214687460 @default.
- W4382752420 cites W4220800089 @default.
- W4382752420 cites W4220873688 @default.
- W4382752420 cites W4225760754 @default.
- W4382752420 cites W4280562953 @default.
- W4382752420 cites W4281687206 @default.
- W4382752420 cites W4281713879 @default.
- W4382752420 cites W4283207872 @default.
- W4382752420 cites W4293217094 @default.
- W4382752420 cites W4297999497 @default.
- W4382752420 cites W4298005897 @default.
- W4382752420 cites W4299462724 @default.
- W4382752420 cites W4306411307 @default.
- W4382752420 cites W4311807675 @default.
- W4382752420 cites W4313561586 @default.
- W4382752420 cites W4318479207 @default.
- W4382752420 cites W4319057949 @default.
- W4382752420 cites W4319596267 @default.
- W4382752420 cites W4320896760 @default.
- W4382752420 cites W4323565352 @default.
- W4382752420 cites W4323852918 @default.
- W4382752420 cites W4362520854 @default.
- W4382752420 cites W4366816754 @default.
- W4382752420 doi "https://doi.org/10.3390/vaccines11071183" @default.
- W4382752420 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37514999" @default.
- W4382752420 hasPublicationYear "2023" @default.
- W4382752420 type Work @default.
- W4382752420 citedByCount "0" @default.
- W4382752420 crossrefType "journal-article" @default.
- W4382752420 hasAuthorship W4382752420A5004509124 @default.
- W4382752420 hasAuthorship W4382752420A5022182326 @default.
- W4382752420 hasAuthorship W4382752420A5022556482 @default.
- W4382752420 hasAuthorship W4382752420A5036098046 @default.
- W4382752420 hasAuthorship W4382752420A5043985132 @default.
- W4382752420 hasAuthorship W4382752420A5044938943 @default.
- W4382752420 hasAuthorship W4382752420A5071213434 @default.
- W4382752420 hasAuthorship W4382752420A5078724506 @default.
- W4382752420 hasAuthorship W4382752420A5081286036 @default.
- W4382752420 hasAuthorship W4382752420A5087196296 @default.
- W4382752420 hasAuthorship W4382752420A5092371828 @default.
- W4382752420 hasBestOaLocation W43827524201 @default.
- W4382752420 hasConcept C104317684 @default.
- W4382752420 hasConcept C116675565 @default.
- W4382752420 hasConcept C126322002 @default.
- W4382752420 hasConcept C127413603 @default.
- W4382752420 hasConcept C146978453 @default.
- W4382752420 hasConcept C159047783 @default.
- W4382752420 hasConcept C159654299 @default.